Sunshine Biopharma (SBFM) Revenue Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFM) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | -0.81% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -0.24% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 0.07% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -1.92% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 4.88% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 39.49% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 10.23% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sunshine Biopharma | 1.52 Mn | -12.23 Mn | 2.43 Mn | -1.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.56% |
| Mar 31, 2026 | -9.13% |
| Dec 31, 2025 | -10.61% |
| Sep 30, 2025 | 11.64% |
| Jun 30, 2025 | 1.15% |
| Mar 31, 2025 | 18.04% |
| Dec 31, 2024 | 24.93% |
| Sep 30, 2024 | 41.59% |
| Jun 30, 2024 | 67.30% |
| Mar 31, 2024 | 54.09% |
| Dec 31, 2023 | 94.94% |
| Sep 30, 2023 | 4,385.93% |
| Jun 30, 2023 | 3,599.67% |
| Mar 31, 2023 | 3,890.42% |
| Dec 31, 2022 | 4,528.68% |
| Sep 30, 2022 | 163.63% |
| Jun 30, 2022 | 184.27% |
| Mar 31, 2022 | 206.17% |
| Dec 31, 2021 | 203.85% |
| Sep 30, 2021 | 193.74% |